文献速递慢性肾脏病血液净化与透析

认知功能障碍预测CKD患者不良结局

Cognitive Impairment Predicts Adverse Outcomes in CKD.
PubMed 文献 · Kidney Int Rep · 2026-03-11

法国CKD-REIN队列纳入3004例CKD 2-5期患者,用MMSE评估认知功能,Cox模型分析全因死亡、肾脏替代治疗(KRT)启动和主要心血管不良事件(MACE)风险。中位随访3.87年,基线MMSE<24分者相比>26分者,KRT启动、全因死亡和MACE风险分别增加42%、57%和32%。

要点

  • CKD患者基线MMSE<24分预示KRT启动、全因死亡和MACE风险升高。
  • MMSE 24-26分亦与全因死亡风险升高相关(HR 1.45)。
  • 早期识别认知障碍有助于个体化管理肾脏和心血管并发症。

核心结论

  • 在CKD患者中,基线MMSE评分<24分相比>26分,预示更高的全因死亡、KRT启动和MACE风险。

研究设计与样本

  • 法国CKD-REIN前瞻性队列,纳入3033例CKD 2-5期患者,随访5年,最终分析3004例。
  • 认知功能用简易精神状态检查(MMSE)评估,eGFR用CKD-EPI肌酐公式估算。
  • 采用Cox模型评估全因死亡、KRT启动和MACE风险。

主要发现

  • 基线MMSE>26、24-26、<24分者分别占64%、23%、13%。
  • 随访平均3.87年,21.5%启动KRT,13.4%死亡,15.3%发生MACE(KRT前或非心血管死亡前)。
  • 调整后,MMSE<24 vs >26:KRT启动HR 1.42(95%CI 1.12-1.81),全因死亡HR 1.57(95%CI 1.19-2.07),MACE HR 1.32(95%CI 1.02-1.70)。
  • MMSE 24-26 vs >26:全因死亡HR 1.45(95%CI 1.15-1.83)。

临床怎么用

  • 对CKD患者可考虑用MMSE筛查认知障碍,识别高风险个体以加强管理。
  • 认知障碍患者需更关注肾脏替代治疗准备和心血管并发症预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Cognitive impairment (CI) affects self-management in chronic diseases, leading to poor decision-making, delayed care, and increased mortality. The specific impact of CI on adverse outcomes in chronic kidney disease (CKD) remains poorly explored. METHODS: The French CKD - Renal Epidemiology and Information Network (CKD-REIN) cohort included 3033 patients with CKD stage 2 to 5 and 5 years of follow-up. CI was assessed using the Mini-Mental State Examination (MMSE), and estimated glomerular filtration rate (eGFR) was estimated using the CKD Epidemiology Collaboration creatinine equation. Cox models evaluated the risks of all-cause mortality, kidney replacement therapy (KRT) initiation, and major adverse cardiovascular (CV) events (MACEs). RESULTS: A total of 3004 patients were included in the analysis (mean age: 67 years, mean eGFR: 34 ml/min per 1.73 m2), and 64%, 23%, and 13%, respectively had MMSE scores > 26, from 24 to 26, and < 24 at baseline. During the follow-up period (mean: 3.87 years), 21.5% of patients initiated KRT, 13.4% died, and 15.3% experienced a MACE before KRT or non-CV death. In adjusted Cox models, patients with a MMSE < 24 had a higher risk of clinical adverse outcome, relative to those with a MMSE > 26: hazard ratio (HR) [95% confidence interval] was 1.42 [1.12-1.81], 1.57 [1.19-2.07], and 1.32 [1.02-1.70] for KRT initiation, all-cause mortality, and MACE, respectively. In addition, CI was associated with all-cause mortality in the MMSE of 24 to 26 group (HR: 1.45, 95% confidence interval: 1.15-1.83). CONCLUSION: In CKD, a baseline MMSE score < 24 predicts higher overall-death, KRT initiation, and MACEs, relative to a baseline score > 26. These results highlight CI's prognostic value, and suggest that earlier detection could better personalize management, particularly for kidney and CV complications.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Levassort H, Hassan Y, Boucquemont J, et al. Cognitive Impairment Predicts Adverse Outcomes in CKD. Kidney Int Rep. 2026. PMID: 42006201. doi:10.1016/j.ekir.2026.106469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。